단일기관 소아청소년 입원환자에서의 허가 외 약물 사용 현황 분석
Analysis of Off-Label Drug Use in Pediatric Inpatients: A Single Tertiary Center Experience
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Because of the lack of clinical research and drug evaluation for children, off-label prescribing has been widely observed in children. However, studies on the prevalence of off-label prescribing in children are rare in Korea. The purpose of this study was to investigate the characteristics of off-label prescribing in pediatric inpatients at a tertiary university hospital in Korea. Methods : All pediatric patients age 0-18 years were included Jun 1-7, 2020 at Asan Medical Center. We retrospectively collected patient characteristics and medication profiles and off-label prescriptions were defined based on the Korea Food and Drug Administration–approved labeling. Results : Of the 286 inpatients, 229 (80.1%) patients received at least one off-label drug use. Additionally, 380 drugs were used, and 129 (33.9%) drugs are not approved in children. Of 1,784 prescriptions, 722 (40.5 %) were for off-label use. The proportion (n=107, 46.7%) of children under age two was higher in the off-label group than in the No off-label group. Gastrointestinal agents (n=183, 25.3%) were the most common causative drugs, followed by cardiovascular agents (n=111, 15.4%), and anti-Infective agents (n=82, 11.4%). Conclusion : Off-label prescribing is common among pediatric patients, especially in premature and neonates. Thus, pediatric pharmacists should be actively engaged in off-label drug use for safe and effective medication use in pediatric patients. A practical guideline for off-label drug use in children, and further research on adverse drug reactions from off-label drug use is needed.
Abstract
Background : Because of the lack of clinical research and drug evaluation for children, off-label prescribing has been widely observed in children. However, studies on the prevalence of off-label prescribing in children are rare in Korea. The purpose of this study was to investigate the characteristics of off-label prescribing in pediatric inpatients at a tertiary university hospital in Korea. Methods : All pediatric patients age 0-18 years were included Jun 1-7, 2020 at Asan Medical Center. We retrospectively collected patient characteristics and medication profiles and off-label prescriptions were defined based on the Korea Food and Drug Administration–approved labeling. Results : Of the 286 inpatients, 229 (80.1%) patients received at least one off-label drug use. Additionally, 380 drugs were used, and 129 (33.9%) drugs are not approved in children. Of 1,784 prescriptions, 722 (40.5 %) were for off-label use. The proportion (n=107, 46.7%) of children under age two was higher in the off-label group than in the No off-label group. Gastrointestinal agents (n=183, 25.3%) were the most common causative drugs, followed by cardiovascular agents (n=111, 15.4%), and anti-Infective agents (n=82, 11.4%). Conclusion : Off-label prescribing is common among pediatric patients, especially in premature and neonates. Thus, pediatric pharmacists should be actively engaged in off-label drug use for safe and effective medication use in pediatric patients. A practical guideline for off-label drug use in children, and further research on adverse drug reactions from off-label drug use is needed.
참고문헌 (14)
- Gregory LK, "Developmental pharmacology-drug disposition, action, and therapy in infants and children", N Engl J Med, 349(12), pp.1157~1167 (2003)
- 조수진, "신생아 임상 연구의 현황과 필요성", Neonatal medicine, 15(2), pp.113~118 (2008), 대한신생아학회
- Joana M, "Use of off-label and unlicenced drugs in hospitalised paediatric patients : a systematic review", Eur J Clin Pharmacol, 71(1), pp.1~13 (2015)
- Laura C, "Unlicensed and off-label uses of drugs in paediatrics : a review of the literature", Fundam Clin Pharmacol, 17(1), pp.125~131 (2003)
- Blumer JL, "Off-label uses of drugs in children", Pediatrics, 104, pp.598~602 (1999)
- 배혜정, "단일기관 신생아중환자실에서의 허가외 약물 사용 현황", 병원약사회지, 36(3), pp.325~334 (2019), 한국병원약사회[DOI]
- Angela SC, "Patterns of off-Label prescribing in the pediatric intensive care unit and prioritizing future research", J Pediatr Pharmacol Ther, 20(3), pp.186~196 (2015)
- Samir S, "Off-label drug use in hospitalized children", Arch Pediatr Adolesc Med, 161(3), pp.282~290 (2007)
- Christine H, "Off-label medication use in children, more common than we think : a systematic review of the literature", J Okla State Med Assoc, 111(8), pp.776~783 (2018)
- Divya H, "Trends in off-label drug use in ambulatory settings : 2006-2015", Pediatrics, 144(4), pp.e20190896~ (2019)
- 피수영, "신생아 진료지침", pp.487~ (2014), 대한신생아학회
- Hansen AR, "Cloherty and Stark’s manual of neonatal care", pp.471~ (2016), Wolters Kluwer
- Gorman RL, "Prevention of medication errors in the pediatric inpatient setting", Pediatrics, 102(2), pp.428~430 (1998)
- Song YK, "International coherence of pediatric drug labeling for drug safety : comparison of approved labels in Korea and the United States", Clinical pharmacology & Therapeutics, 107(3), pp.530~540 (2020)